CliffBio
small molecule

ALBUTEROL SULFATE

ALBUTEROL SULFATE

Loss of exclusivity—loss of exclusivity
CompanyUCB →See this company's full patent-cliff portfolio

Drug detail

Brand nameALBUTEROL SULFATE
Active ingredientALBUTEROL SULFATE
StrengthEQ 4MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 1992
Marketing statusDISCN

More from UCB

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ALBUTEROL SULFATE patent cliff — loss of exclusivity — | CliffBio